title: Fetal alcohol effects: mechanisms and treatment.
abstract: This article represents the proceedings of a symposium at the 2000 ISBRA Meeting in Yokohama, Japan. The chair was Edward P. Riley. The presentations were (1) Does alcohol withdrawal contribute to fetal alcohol effects? by Jennifer D. Thomas and Edward P. Riley; (2) Brain damage and neuroplasticity in an animal model of binge alcohol exposure during the "third trimester equivalent," by Charles R. Goodlett, Anna Y. Klintsova, and William T. Greenough; (3) Ganglioside GM1 reduces fetal alcohol effects, by Basalingappa L. Hungund; and (4) Fetal alcohol exposure alters the wiring of serotonin system at mid-gestation, by F. Zhou, Y. Sari, Charles Goodlett, T. Powrozek, and Ting-Kai Li.
authors.affiliation: Center for Behavioral Teratology (EPR, JDT), Department of Psychology, San Diego State University, San Diego, California 92120, USA. eriley@mail.sdsu.edu
authors.forename: E P
authors.initials: EP
authors.lastname: Riley
authors.forename: J D
authors.initials: JD
authors.lastname: Thomas
authors.forename: C R
authors.initials: CR
authors.lastname: Goodlett
authors.forename: A Y
authors.initials: AY
authors.lastname: Klintsova
authors.forename: W T
authors.initials: WT
authors.lastname: Greenough
authors.forename: B L
authors.initials: BL
authors.lastname: Hungund
authors.forename: F
authors.initials: F
authors.lastname: Zhou
authors.forename: Y
authors.initials: Y
authors.lastname: Sari
authors.forename: T
authors.initials: T
authors.lastname: Powrozek
authors.forename: T K
authors.initials: TK
authors.lastname: Li
mesh_terms: D000818:Animals; D016923:Cell Death / Q000187:drug effects / Q000502:physiology; D002492:Central Nervous System Depressants / Q000009:adverse effects*; D002531:Cerebellum / Q000187:drug effects* / Q000196:embryology / Q000473:pathology; D016291:Dizocilpine Maleate / Q000494:pharmacology; D000431:Ethanol / Q000009:adverse effects*; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D005260:Female; D063647:Fetal Alcohol Spectrum Disorders / Q000196:embryology / Q000378:metabolism* / Q000473:pathology; D005732:Gangliosides / Q000378:metabolism*; D006801:Humans; D009412:Nerve Fibers / Q000187:drug effects / Q000473:pathology; D011247:Pregnancy; D051381:Rats; D016194:Receptors, N-Methyl-D-Aspartate / Q000187:drug effects / Q000378:metabolism; D012701:Serotonin / Q000378:metabolism*; D013375:Substance Withdrawal Syndrome / Q000378:metabolism*
chemical_list: D002492:Central Nervous System Depressants; D018691:Excitatory Amino Acid Antagonists; D005732:Gangliosides; D016194:Receptors, N-Methyl-D-Aspartate; D012701:Serotonin; D000431:Ethanol; D016291:Dizocilpine Maleate